School of Medicine
Showing 1-10 of 82 Results
-
Steven Artandi, MD, PhD
Laurie Kraus Lacob Director of the Stanford Cancer Institute (SCI), Jerome and Daisy Low Gilbert Professor and Professor of Biochemistry
Current Research and Scholarly InterestsTelomeres are nucleoprotein complexes that protect chromosome ends and shorten with cell division and aging. We are interested in how telomere shortening influences cancer, stem cell function, aging and human disease. Telomerase is a reverse transcriptase that synthesizes telomere repeats and is expressed in stem cells and in cancer. We have found that telomerase also regulates stem cells and we are pursuing the function of telomerase through diverse genetic and biochemical approaches.
-
Pamela A. Basto
Fellow in Medicine - Med/Hematology
BioDr. Basto is a physician scientist and medical oncologist specializing in the diagnosis and treatment of gastrointestinal malignancies.
She attended The University of Texas graduating magna sum laude in biomedical engineering, subsequently gaining her Ph.D. in Medical Engineering and Medical Physics at the Harvard-MIT Health Science and Technology program the under the tutelage of Professors Robert Langer and Ulrich von Andrian at the Koch Institute for Integrative Cancer Research. Her thesis focused on developing next generation polymeric nanoparticle vaccines towards improved antigen specific cellular and humoral responses, work that has been translated into clinical trials. She completed medical school at Stanford University, followed by residency in internal medicine at The Mount Sinai Hospital in NYC in the ABIM research pathway, where she served on the ICU frontlines during the COVID-alpha wave in New York at Elmhurst Hospital. She subsequently completed her hematology/oncology fellowship at Stanford University training in Professor Edgar Engleman’s lab in tumor immunology. Her research studies how gastrointestinal cancers metastasize leveraging the immune system and engineering novel therapeutics targeting abnormal carbohydrates seen on metastases. She is mentored by Professor Lipika Goyal in the clinical and trial management in hepatopancreatobiliary cancers.
As a clinician, she strides to create a welcoming partnership with her patients during a difficult diagnosis based in trust and science, supported by an excellent clinical research team. She welcomes patients from different backgrounds and aims to honor their values in culture, religion, and gender preferences. Her approach is to offer evidence based knowledge and the latest available treatments, including clinical trials, personalized to each individual’s tumor biology and their values. -
Ami Bhatt
Professor of Medicine (Hematology) and of Genetics
Current Research and Scholarly InterestsThe Bhatt lab is exploring how the microbiota is intertwined with states of health and disease. We apply the most modern genetic tools in an effort to deconvolute the mechanism of human diseases.
-
Linda Boxer, MD, PhD
Vice Dean of the School of Medicine and Stanley McCormick Memorial Professor
Current Research and Scholarly InterestsRegulation of expression of oncogenes in normal and malignant hematologic cells.
-
Rondeep Brar
Clinical Professor, Medicine - Hematology
BioAs the Chief Medical Officer of Cancer Care at Stanford Health Care, it is my privilege to partner with my colleagues in advancing innovative research alongside high quality, coordinated, and compassionate care.
I aim to provide high quality care in a diverse patient practice. My clinic includes all types of hematologic disorders, ranging from anemia, clotting/bleeding disorders, and low blood counts to complex malignancies such as leukemia, myelodysplastic syndrome, myeloma, and lymphoma. I aim to combine the efficiency of a private office with the complex care expected of a tertiary institution like Stanford. I value your time and strive to maintain an on-schedule clinic.
